In general, cancer incidence is projected to rise significantly, with global cases expected to increase by 20% by 2030 and ...

S&E bio Co., Ltd., a biotechnology company specializing in exosomal microRNA-based therapies, has received approval from Korea's Ministry of Food and Drug Safety (MFDS) to initiate a Phase 1b clinical ...

Fermenta Biotech Limited (Fermenta) proudly steps into its 75th year, beginning a momentous chapter in its journey of trust, ...

According to the latest study from BCC Research, the "Global Fluorescence Microscopy Market" is expected to grow from $968.5 ...

Decentralized Biotechnology Intelligence Holding Group Inc. (dBio), a leading innovator in sports and health tech, delivering ...

Bert Hoyt, exvicepresidente y gerente general de Nike, se une a dBio como asesor de la junta para impulsar la tecnología ...

PhaseV, a leader in AI/ML-driven clinical development, today announced that the second episode in its webinar series will focus on improving patient-centricity and efficiency in clinical trial design.

A sudden rollback of federal funding for public health research has jolted the US pharma landscape. With governors in 23 US states questioning the rollback, India sees both a warning and an ...

Shanghai-based VelaVigo has been busy. The biotech granted Avenzo Therapeutics ex-China rights to a Nectin4xTROP2 bispecific antibody-drug conjugate in November, netting up to $50 million in ...

ADGHW is a major government initiative from DoH and serves as a platform for innovation and collaboration under the theme ...